Neurophet뉴로핏
380550 · KOSDAQ · ₩380550 · 뉴로핏
₩6,260▼ ₩280 (4.28%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | |
|---|---|---|---|---|
| Revenue | ₩782M | ₩481M | ₩563M | ₩763M |
| Operating income | −₩5.2B | −₩5.8B | −₩4.4B | −₩4.2B |
| Net income | −₩5.7B | −₩5.7B | −₩4.9B | −₩6.8B |
| Net income to shareholders | −₩5.7B | −₩5.7B | −₩4.9B | −₩6.8B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | |
|---|---|---|---|---|
| Total assets | ₩50B | ₩22B | ₩27B | ₩31B |
| Current assets | ₩47B | ₩20B | ₩25B | ₩29B |
| Cash and equivalents | ₩3.8B | ₩4B | ₩4.1B | ₩2.1B |
| Total liabilities | ₩15B | ₩3B | ₩7.4B | ₩13B |
| Current liabilities | ₩2.2B | ₩2.5B | ₩6.9B | ₩13B |
| Borrowings | ₩6.2B | — | ₩4.8B | ₩4.4B |
| Total equity | ₩35B | ₩19B | ₩19B | ₩18B |
| Shareholders' equity | ₩35B | ₩19B | ₩19B | ₩18B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | |
|---|---|---|---|---|
| Cash from operations | −₩5.1B | −₩4.7B | −₩4.1B | −₩3.8B |
| Capital spending | ₩65M | ₩375M | ₩34M | ₩61M |
| Free cash flow | −₩5.2B | −₩5.1B | −₩4.1B | −₩3.9B |
Consolidated where available. Amounts in won.
Also known as: Neurophet / 뉴로핏 / 380550 / KRX:380550
Source: KRX statistical information